{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:44Z","timestamp":1793237684789,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacadv.2026.103031","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:15:24Z","timestamp":1784560524000},"page":"103031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zero Coronary Artery Calcium as a Marker of Vascular Resilience in High-Risk Adults"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6858-1057","authenticated-orcid":false,"given":"Olusola A.","family":"Orimoloye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7247-5257","authenticated-orcid":false,"given":"Olufunmilayo H.","family":"Obisesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Osei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omotola","family":"Oredipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes R.","family":"Carnethon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Rasmussen-Torvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.103031_bib1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2026.103031_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib3","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease","volume":"74(10)","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103031_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jacc.2022.05.015","article-title":"New cardiovascular risk assessment techniques for primary prevention","volume":"80","author":"Verma","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103031_bib5","first-page":"598","article-title":"Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the ACC\/AHA ASCVD risk score in a modern multi-ethnic cohort","volume":"38","author":"DeFilippis","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103031_bib6","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib7","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/eurheartj\/ehy217","article-title":"Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"39","author":"Budoff","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103031_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.115.018524","article-title":"Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"133","author":"Blaha","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103031_bib9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2015.07.066","article-title":"Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology\/American Heart Association cholesterol management guidelines: MESA","volume":"66","author":"Nasir","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103031_bib10","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/eurheartj\/eht508","article-title":"Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"Silverman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103031_bib11","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jcmg.2018.09.019","article-title":"Coronary artery calcium and cardiovascular events in patients with familial hypercholesterolemia receiving standard lipid-lowering therapy","volume":"12","author":"Miname","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2026.103031_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-Ethnic Study of Atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacadv.2026.103031_bib13","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103031_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib15","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jacadv.2026.103031_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103031_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103031_bib19","article-title":"Risk matters for atherosclerotic cardiovascular disease: but vascular resilience may decide","volume":"24","author":"Shapiro","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacadv.2026.103031_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/CIRCIMAGING.111.964528","article-title":"Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals","volume":"5","author":"Nasir","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2026.103031_bib21","article-title":"PREVENT risk score vs the Pooled Cohort Equations in MESA","volume":"4","author":"Murphy","year":"2025","journal-title":"JACC: Adv"},{"key":"10.1016\/j.jacadv.2026.103031_bib22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jcmg.2019.11.001","article-title":"Absence of coronary artery calcification in middle-aged familial hypercholesterolemia patients without atherosclerotic cardiovascular disease","volume":"13","author":"Mszar","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2026.103031_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jacl.2022.07.007","article-title":"Predicting resilience in heterozygous familial hypercholesterolaemia: a cohort study of octogenarian patients","volume":"16","author":"Perez de Isla","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacadv.2026.103031_bib24","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.3390\/ijms25094831","article-title":"Resilient older subjects with heterozygous familial hypercholesterolemia, baseline differences and associated factors","volume":"25","author":"Climent","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacadv.2026.103031_bib25","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib28","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa1508419","article-title":"Variant ASGR1 associated with a reduced risk of coronary artery disease","volume":"374","author":"Nioi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103031_bib31","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehae325","article-title":"Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy","volume":"45","author":"Gaudet","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103031_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.016377","article-title":"Polygenic risk scores and extreme coronary artery calcium phenotypes (CAC=0 and CAC>=1000) in adults >=75 years old: the ARIC study","volume":"17","author":"Dzaye","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2026.103031_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.116.021803","article-title":"Aptamer-based proteomic profiling reveals novel candidate biomarkers and pathways in cardiovascular disease","volume":"134","author":"Ngo","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103031_bib34","article-title":"Plasma proteomic profiles predict the risk of coronary artery disease in the UK Biobank cohort","author":"Zhang","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.jacadv.2026.103031_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031459","article-title":"Genome-wide association study of cardiovascular resilience identifies protective variation in the CETP gene","volume":"12","author":"Yu","year":"2023","journal-title":"J Am Heart Assoc"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:28:41Z","timestamp":1793237321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26004527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2772963X26004527"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103031","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zero Coronary Artery Calcium as a Marker of Vascular Resilience in High-Risk Adults","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103031"}}